{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T18:49:58Z","timestamp":1778698198635,"version":"3.51.4"},"reference-count":107,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,5,10]],"date-time":"2021-05-10T00:00:00Z","timestamp":1620604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,5,10]],"date-time":"2021-05-10T00:00:00Z","timestamp":1620604800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R35HL135820"],"award-info":[{"award-number":["R35HL135820"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["20TPA35490416"],"award-info":[{"award-number":["20TPA35490416"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Atheroscler Rep"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s11883-021-00934-3","type":"journal-article","created":{"date-parts":[[2021,5,10]],"date-time":"2021-05-10T12:03:20Z","timestamp":1620648200000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["MicroRNAs and Circular RNAs in Lipoprotein Metabolism"],"prefix":"10.1007","volume":"23","author":[{"given":"Pablo","family":"Fern\u00e1ndez-Tussy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inmaculada","family":"Ruz-Maldonado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3950-1924","authenticated-orcid":false,"given":"Carlos","family":"Fern\u00e1ndez-Hernando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,10]]},"reference":[{"issue":"4","key":"934_CR1","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/S0092-8674(01)00238-0","volume":"104","author":"CK Glass","year":"2001","unstructured":"Glass CK, Witztum JL. Atherosclerosis. The road ahead. Cell. 2001;104(4):503\u201316.","journal-title":"Cell"},{"issue":"239","key":"934_CR2","doi-asserted-by":"publisher","first-page":"239ps233","DOI":"10.1126\/scitranslmed.3009008","volume":"6","author":"EN Olson","year":"2014","unstructured":"Olson EN. MicroRNAs as therapeutic targets and biomarkers of cardiovascular disease. Sci Transl Med. 2014;6(239):239ps233.","journal-title":"Sci Transl Med"},{"key":"934_CR3","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.vph.2018.06.011","volume":"114","author":"X Zhang","year":"2019","unstructured":"Zhang X, Price NL, Fernandez-Hernando C. Non-coding RNAs in lipid metabolism. Vasc Pharmacol. 2019;114:93\u2013102.","journal-title":"Vasc Pharmacol"},{"issue":"7006","key":"934_CR4","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/nature02871","volume":"431","author":"V Ambros","year":"2004","unstructured":"Ambros V. The functions of animal microRNAs. Nature. 2004;431(7006):350\u20135.","journal-title":"Nature"},{"issue":"2","key":"934_CR5","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1097\/MOL.0b013e3283428d9d","volume":"22","author":"C Fernandez-Hernando","year":"2011","unstructured":"Fernandez-Hernando C, Suarez Y, Rayner KJ, Moore KJ. MicroRNAs in lipid metabolism. Curr Opin Lipidol. 2011;22(2):86\u201392.","journal-title":"Curr Opin Lipidol"},{"issue":"11","key":"934_CR6","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41576-019-0158-7","volume":"20","author":"LS Kristensen","year":"2019","unstructured":"Kristensen LS, Andersen MS, Stagsted LVW, Ebbesen KK, Hansen TB, Kjems J. The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet. 2019;20(11):675\u201391.","journal-title":"Nat Rev Genet"},{"key":"934_CR7","doi-asserted-by":"publisher","first-page":"117837","DOI":"10.1016\/j.lfs.2020.117837","volume":"255","author":"Q Cao","year":"2020","unstructured":"Cao Q, Guo Z, Du S, Ling H, Song C. Circular RNAs in the pathogenesis of atherosclerosis. Life Sci. 2020;255:117837.","journal-title":"Life Sci"},{"key":"934_CR8","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.omtn.2020.05.024","volume":"21","author":"S Zhang","year":"2020","unstructured":"Zhang S, Wang W, Wu X, Zhou X. Regulatory roles of circular RNAs in coronary artery disease. Mol Ther Nucleic Acids. 2020;21:172\u20139.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"9","key":"934_CR9","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.15252\/emmm.201404046","volume":"6","author":"L Goedeke","year":"2014","unstructured":"Goedeke L, Salerno A, Ramirez CM, et al. Long-term therapeutic silencing of miR-33 increases circulating triglyceride levels and hepatic lipid accumulation in mice. EMBO Mol Med. 2014;6(9):1133\u201341.","journal-title":"EMBO Mol Med"},{"issue":"11","key":"934_CR10","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1038\/nm.3949","volume":"21","author":"L Goedeke","year":"2015","unstructured":"Goedeke L, Rotllan N, Canfran-Duque A, et al. MicroRNA-148a regulates LDL receptor and ABCA1 expression to control circulating lipoprotein levels. Nat Med. 2015;21(11):1280\u20139.","journal-title":"Nat Med"},{"issue":"12 Pt B","key":"934_CR11","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1016\/j.bbalip.2016.03.007","volume":"1861","author":"L Goedeke","year":"2016","unstructured":"Goedeke L, Wagschal A, Fernandez-Hernando C, Naar AM. miRNA regulation of LDL-cholesterol metabolism. Biochim Biophys Acta. 2016;1861(12 Pt B):2047\u201352.","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"934_CR12","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1097\/MOL.0000000000000420","volume":"28","author":"B Aryal","year":"2017","unstructured":"Aryal B, Singh AK, Rotllan N, Price N, Fernandez-Hernando C. MicroRNAs and lipid metabolism. Curr Opin Lipidol. 2017;28(3):273\u201380.","journal-title":"Curr Opin Lipidol"},{"issue":"5985","key":"934_CR13","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1126\/science.1189862","volume":"328","author":"KJ Rayner","year":"2010","unstructured":"Rayner KJ, Suarez Y, Davalos A, Parathath S, Fitzgerald ML, Tamehiro N, et al. MiR-33 contributes to the regulation of cholesterol homeostasis. Science. 2010;328(5985):1570\u20133.","journal-title":"Science"},{"issue":"11","key":"934_CR14","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1038\/nm.3980","volume":"21","author":"A Wagschal","year":"2015","unstructured":"Wagschal A, Najafi-Shoushtari SH, Wang L, Goedeke L, Sinha S, deLemos AS, et al. Genome-wide identification of microRNAs regulating cholesterol and triglyceride homeostasis. Nat Med. 2015;21(11):1290\u20137.","journal-title":"Nat Med"},{"issue":"3","key":"934_CR15","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.cell.2020.09.017","volume":"183","author":"L Wang","year":"2020","unstructured":"Wang L, Sinnott-Armstrong N, Wagschal A, Wark AR, Camporez JP, Perry RJ, et al. A MicroRNA linking human positive selection and metabolic disorders. Cell. 2020;183(3):684\u2013701 e614.","journal-title":"Cell"},{"issue":"23","key":"934_CR16","doi-asserted-by":"publisher","first-page":"e143812","DOI":"10.1172\/jci.insight.143812","volume":"5","author":"J Dong","year":"2020","unstructured":"Dong J, He M, Li J, et al. microRNA-483 ameliorates hypercholesterolemia by inhibiting PCSK9 production. JCI Insight. 2020;5(23):e143812.","journal-title":"JCI Insight"},{"key":"934_CR17","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3389\/fcvm.2020.00081","volume":"7","author":"AG Salerno","year":"2020","unstructured":"Salerno AG, van Solingen C, Scotti E, Wanschel ACBA, Afonso MS, Oldebeken SR, et al. LDL receptor pathway regulation by miR-224 and miR-520d. Front Cardiovasc Med. 2020;7:81.","journal-title":"Front Cardiovasc Med"},{"issue":"7","key":"934_CR18","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1038\/nm.3200","volume":"19","author":"J Soh","year":"2013","unstructured":"Soh J, Iqbal J, Queiroz J, Fernandez-Hernando C, Hussain MM. MicroRNA-30c reduces hyperlipidemia and atherosclerosis in mice by decreasing lipid synthesis and lipoprotein secretion. Nat Med. 2013;19(7):892\u2013900.","journal-title":"Nat Med"},{"issue":"9","key":"934_CR19","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/S0960-9822(02)00809-6","volume":"12","author":"M Lagos-Quintana","year":"2002","unstructured":"Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W, Tuschl T. Identification of tissue-specific microRNAs from mouse. Curr Biol. 2002;12(9):735\u20139.","journal-title":"Curr Biol"},{"issue":"4","key":"934_CR20","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.jhep.2008.01.019","volume":"48","author":"M Girard","year":"2008","unstructured":"Girard M, Jacquemin E, Munnich A, Lyonnet S. Henrion-Caude A: miR-122, a paradigm for the role of microRNAs in the liver. J Hepatol. 2008;48(4):648\u201356.","journal-title":"J Hepatol"},{"issue":"2","key":"934_CR21","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.jhep.2014.10.004","volume":"62","author":"S Bandiera","year":"2015","unstructured":"Bandiera S, Pfeffer S, Baumert TF. Zeisel MB: miR-122\u2014a key factor and therapeutic target in liver disease. J Hepatol. 2015;62(2):448\u201357.","journal-title":"J Hepatol"},{"issue":"12","key":"934_CR22","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1161\/CIRCRESAHA.112.300626","volume":"112","author":"CM Ramirez","year":"2013","unstructured":"Ramirez CM, Rotllan N, Vlassov AV, et al. Control of cholesterol metabolism and plasma high-density lipoprotein levels by microRNA-144. Circ Res. 2013;112(12):1592\u2013601.","journal-title":"Circ Res"},{"issue":"1","key":"934_CR23","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.ymthe.2019.09.008","volume":"28","author":"Y Xu","year":"2020","unstructured":"Xu Y, Xu Y, Zhu Y, Sun H, Juguilon C, Li F, et al. Macrophage miR-34a is a key regulator of cholesterol efflux and atherosclerosis. Mol Ther. 2020;28(1):202\u201316.","journal-title":"Mol Ther"},{"key":"934_CR24","unstructured":"Feingold KR, Grunfeld C: Introduction to lipids and lipoproteins. In: Endotext. Edited by Feingold KR, Anawalt B, Boyce A, et al. South Dartmouth (MA); 2000."},{"issue":"23","key":"934_CR25","doi-asserted-by":"publisher","first-page":"13294","DOI":"10.1073\/pnas.231490498","volume":"98","author":"M Merkel","year":"2001","unstructured":"Merkel M, Velez-Carrasco W, Hudgins LC, Breslow JL. Compared with saturated fatty acids, dietary monounsaturated fatty acids and carbohydrates increase atherosclerosis and VLDL cholesterol levels in LDL receptor-deficient, but not apolipoprotein E-deficient, mice. Proc Natl Acad Sci U S A. 2001;98(23):13294\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"934_CR26","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.cmet.2009.06.003","volume":"10","author":"C Fernandez-Hernando","year":"2009","unstructured":"Fernandez-Hernando C, Yu J, Suarez Y, et al. Genetic evidence supporting a critical role of endothelial caveolin-1 during the progression of atherosclerosis. Cell Metab. 2009;10(1):48\u201354.","journal-title":"Cell Metab"},{"issue":"3","key":"934_CR27","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1161\/CIRCULATIONAHA.118.038571","volume":"140","author":"CM Ramirez","year":"2019","unstructured":"Ramirez CM, Zhang X, Bandyopadhyay C, et al. Caveolin-1 regulates atherogenesis by attenuating low-density lipoprotein transcytosis and vascular inflammation independently of endothelial nitric oxide synthase activation. Circulation. 2019;140(3):225\u201339.","journal-title":"Circulation"},{"key":"934_CR28","doi-asserted-by":"publisher","first-page":"9930","DOI":"10.1038\/srep09930","volume":"5","author":"C Shi","year":"2015","unstructured":"Shi C, Zhang M. Tong M, et al: miR-148a is associated with obesity and modulates adipocyte differentiation of mesenchymal stem cells through Wnt signaling. Sci Rep. 2015;5:9930.","journal-title":"Sci Rep"},{"issue":"11","key":"934_CR29","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1038\/ng.2797","volume":"45","author":"CJ Willer","year":"2013","unstructured":"Willer CJ, Schmidt EM, Sengupta S, Peloso GM, Gustafsson S, Kanoni S, et al. Discovery and refinement of loci associated with lipid levels. Nat Genet. 2013;45(11):1274\u201383.","journal-title":"Nat Genet"},{"issue":"11","key":"934_CR30","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1038\/ng.2795","volume":"45","author":"R Do","year":"2013","unstructured":"Do R, Willer CJ, Schmidt EM, Sengupta S, Gao C, Peloso GM, et al. Common variants associated with plasma triglycerides and risk for coronary artery disease. Nat Genet. 2013;45(11):1345\u201352.","journal-title":"Nat Genet"},{"key":"934_CR31","doi-asserted-by":"publisher","first-page":"6601","DOI":"10.1038\/ncomms7601","volume":"6","author":"T Huan","year":"2015","unstructured":"Huan T, Rong J, Liu C, Zhang X, Tanriverdi K, Joehanes R, et al. Genome-wide identification of microRNA expression quantitative trait loci. Nat Commun. 2015;6:6601.","journal-title":"Nat Commun"},{"issue":"5","key":"934_CR32","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1002\/ijc.24008","volume":"124","author":"J Shen","year":"2009","unstructured":"Shen J, Ambrosone CB, Zhao H. Novel genetic variants in microRNA genes and familial breast cancer. Int J Cancer. 2009;124(5):1178\u201382.","journal-title":"Int J Cancer"},{"issue":"3","key":"934_CR33","doi-asserted-by":"publisher","first-page":"2788","DOI":"10.1002\/jcp.27095","volume":"234","author":"PF Zhang","year":"2019","unstructured":"Zhang PF, Wang F, Wu J, Wu Y, Huang W, Liu D, et al. LncRNA SNHG3 induces EMT and sorafenib resistance by modulating the miR-128\/CD151 pathway in hepatocellular carcinoma. J Cell Physiol. 2019;234(3):2788\u201394.","journal-title":"J Cell Physiol"},{"issue":"2","key":"934_CR34","first-page":"644","volume":"54","author":"J Jin","year":"2019","unstructured":"Jin J, Guo T, Guo Y, Liu J, Qu F, He Y. Methylationassociated silencing of miR128 promotes the development of esophageal cancer by targeting COX2 in areas with a high incidence of esophageal cancer. Int J Oncol. 2019;54(2):644\u201354.","journal-title":"Int J Oncol"},{"issue":"5","key":"934_CR35","doi-asserted-by":"publisher","first-page":"e25","DOI":"10.1161\/HYPERTENSIONAHA.118.12476","volume":"73","author":"Q Lu","year":"2019","unstructured":"Lu Q, Meng Q, Qi M, Li F, Liu B. Shear-sensitive lncRNA AF131217.1 inhibits inflammation in HUVECs via regulation of KLF4. Hypertension. 2019;73(5):e25\u201334.","journal-title":"Hypertension"},{"issue":"2","key":"934_CR36","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/s41388-018-0432-8","volume":"38","author":"F He","year":"2019","unstructured":"He F, Song Z, Chen H, Chen Z, Yang P, Li W, et al. Long noncoding RNA PVT1-214 promotes proliferation and invasion of colorectal cancer by stabilizing Lin28 and interacting with miR-128. Oncogene. 2019;38(2):164\u201379.","journal-title":"Oncogene"},{"issue":"12","key":"934_CR37","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1101\/gr.2845604","volume":"14","author":"O Barad","year":"2004","unstructured":"Barad O, Meiri E, Avniel A, Aharonov R, Barzilai A, Bentwich I, et al. MicroRNA expression detected by oligonucleotide microarrays: system establishment and expression profiling in human tissues. Genome Res. 2004;14(12):2486\u201394.","journal-title":"Genome Res"},{"issue":"Pt 12","key":"934_CR38","first-page":"2678","volume":"126","author":"N Motohashi","year":"2013","unstructured":"Motohashi N, Alexander MS, Shimizu-Motohashi Y, Myers JA, Kawahara G, Kunkel LM. Regulation of IRS1\/Akt insulin signaling by microRNA-128a during myogenesis. J Cell Sci. 2013;126(Pt 12):2678\u201391.","journal-title":"J Cell Sci"},{"key":"934_CR39","unstructured":"Bjornsson E, Gunnarsdottir K, Halldorsson GH, et al. Lifelong reduction in LDL cholesterol due to a gain-of-function mutation in LDLR. Circ Genom Precis Med. 2020."},{"key":"934_CR40","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1186\/1471-2164-13-552","volume":"13","author":"E Bostjancic","year":"2012","unstructured":"Bostjancic E, Zidar N, Glavac D. MicroRNAs and cardiac sarcoplasmic reticulum calcium ATPase-2 in human myocardial infarction: expression and bioinformatic analysis. BMC Genomics. 2012;13:552.","journal-title":"BMC Genomics"},{"issue":"6","key":"934_CR41","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/cdd.2011.183","volume":"19","author":"D Ferland-McCollough","year":"2012","unstructured":"Ferland-McCollough D, Fernandez-Twinn DS, Cannell IG, David H, Warner M, Vaag AA, et al. Programming of adipose tissue miR-483-3p and GDF-3 expression by maternal diet in type 2 diabetes. Cell Death Differ. 2012;19(6):1003\u201312.","journal-title":"Cell Death Differ"},{"issue":"12","key":"934_CR42","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1093\/carcin\/bgs289","volume":"33","author":"W Wang","year":"2012","unstructured":"Wang W, Zhao LJ, Yang Y, Wang RY, Ren H, Zhao P, et al. Retinoic acid induced 16 enhances tumorigenesis and serves as a novel tumor marker for hepatocellular carcinoma. Carcinogenesis. 2012;33(12):2578\u201385.","journal-title":"Carcinogenesis"},{"issue":"1","key":"934_CR43","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.mce.2010.11.027","volume":"333","author":"N Ma","year":"2011","unstructured":"Ma N, Wang X, Qiao Y, Li F, Hui Y, Zou C, et al. Coexpression of an intronic microRNA and its host gene reveals a potential role for miR-483-5p as an IGF2 partner. Mol Cell Endocrinol. 2011;333(1):96\u2013101.","journal-title":"Mol Cell Endocrinol"},{"issue":"19","key":"934_CR44","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","volume":"285","author":"Expert Panel on Detection E","year":"2001","unstructured":"Expert Panel on Detection E. Treatment of high blood cholesterol in A: executive summary of The Third Report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA. 2001;285(19):2486\u201397.","journal-title":"JAMA"},{"key":"934_CR45","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3389\/fgene.2017.00189","volume":"8","author":"P Naeli","year":"2017","unstructured":"Naeli P, Mirzadeh Azad F, Malakootian M, Seidah NG, Mowla SJ. Post-transcriptional regulation of PCSK9 by miR-191, miR-222, and miR-224. Front Genet. 2017;8:189.","journal-title":"Front Genet"},{"issue":"2","key":"934_CR46","doi-asserted-by":"publisher","first-page":"137","DOI":"10.4161\/rna.18827","volume":"9","author":"C Jopling","year":"2012","unstructured":"Jopling C. Liver-specific microRNA-122: biogenesis and function. RNA Biol. 2012;9(2):137\u201342.","journal-title":"RNA Biol"},{"issue":"2","key":"934_CR47","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.cmet.2006.01.005","volume":"3","author":"C Esau","year":"2006","unstructured":"Esau C, Davis S. Murray SF, et al: miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab. 2006;3(2):87\u201398.","journal-title":"Cell Metab"},{"issue":"6","key":"934_CR48","doi-asserted-by":"publisher","first-page":"E1195","DOI":"10.1152\/ajpendo.90958.2008","volume":"296","author":"K Takeuchi","year":"2009","unstructured":"Takeuchi K, Reue K. Biochemistry, physiology, and genetics of GPAT, AGPAT, and lipin enzymes in triglyceride synthesis. Am J Physiol Endocrinol Metab. 2009;296(6):E1195\u2013209.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"3","key":"934_CR49","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1194\/jlr.M028472","volume":"54","author":"A Vila-Brau","year":"2013","unstructured":"Vila-Brau A, De Sousa-Coelho AL, Goncalves JF, Haro D, Marrero PF. Fsp27\/CIDEC is a CREB target gene induced during early fasting in liver and regulated by FA oxidation rate. J Lipid Res. 2013;54(3):592\u2013601.","journal-title":"J Lipid Res"},{"issue":"5","key":"934_CR50","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s12012-020-09603-4","volume":"20","author":"Y Liu","year":"2020","unstructured":"Liu Y, Song JW, Lin JY, Miao R, Zhong JC. Roles of microRNA-122 in cardiovascular fibrosis and related diseases. Cardiovasc Toxicol. 2020;20(5):463\u201373.","journal-title":"Cardiovasc Toxicol"},{"issue":"1","key":"934_CR51","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12967-017-1176-x","volume":"15","author":"N Martinez-Micaelo","year":"2017","unstructured":"Martinez-Micaelo N, Beltran-Debon R, Baiges I, Faiges M, Alegret JM. Specific circulating microRNA signature of bicuspid aortic valve disease. J Transl Med. 2017;15(1):76.","journal-title":"J Transl Med"},{"key":"934_CR52","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.5218","volume":"6","author":"YL Wang","year":"2018","unstructured":"Wang YL, Yu W. Association of circulating microRNA-122 with presence and severity of atherosclerotic lesions. PeerJ. 2018;6:e5218.","journal-title":"PeerJ"},{"key":"934_CR53","doi-asserted-by":"publisher","first-page":"116590","DOI":"10.1016\/j.lfs.2019.116590","volume":"232","author":"Y Li","year":"2019","unstructured":"Li Y, Yang N, Dong B, Yang J, Kou L, Qin Q. MicroRNA-122 promotes endothelial cell apoptosis by targeting XIAP: therapeutic implication for atherosclerosis. Life Sci. 2019;232:116590.","journal-title":"Life Sci"},{"issue":"2","key":"934_CR54","doi-asserted-by":"publisher","first-page":"347","DOI":"10.2337\/db16-0731","volume":"66","author":"P Willeit","year":"2017","unstructured":"Willeit P, Skroblin P, Moschen AR, Yin X, Kaudewitz D, Zampetaki A, et al. Circulating microRNA-122 is associated with the risk of new-onset metabolic syndrome and type 2 diabetes. Diabetes. 2017;66(2):347\u201357.","journal-title":"Diabetes"},{"issue":"8","key":"934_CR55","doi-asserted-by":"publisher","first-page":"2884","DOI":"10.1172\/JCI63455","volume":"122","author":"WC Tsai","year":"2012","unstructured":"Tsai WC, Hsu SD, Hsu CS, Lai TC, Chen SJ, Shen R, et al. MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis. J Clin Invest. 2012;122(8):2884\u201397.","journal-title":"J Clin Invest"},{"issue":"8","key":"934_CR56","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1172\/JCI63539","volume":"122","author":"SH Hsu","year":"2012","unstructured":"Hsu SH, Wang B, Kota J, Yu J, Costinean S, Kutay H, et al. Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver. J Clin Invest. 2012;122(8):2871\u201383.","journal-title":"J Clin Invest"},{"issue":"5","key":"934_CR57","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.cmet.2008.03.001","volume":"7","author":"AR Tall","year":"2008","unstructured":"Tall AR, Yvan-Charvet L, Terasaka N, Pagler T, Wang N. HDL, ABC transporters, and cholesterol efflux: implications for the treatment of atherosclerosis. Cell Metab. 2008;7(5):365\u201375.","journal-title":"Cell Metab"},{"issue":"10","key":"934_CR58","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1161\/CIRCRESAHA.119.312617","volume":"124","author":"M Ouimet","year":"2019","unstructured":"Ouimet M, Barrett TJ, Fisher EA. HDL and reverse cholesterol transport. Circ Res. 2019;124(10):1505\u201318.","journal-title":"Circ Res"},{"issue":"4","key":"934_CR59","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/11914","volume":"22","author":"M Bodzioch","year":"1999","unstructured":"Bodzioch M, Orso E, Klucken J, et al. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat Genet. 1999;22(4):347\u201351.","journal-title":"Nat Genet"},{"issue":"2","key":"934_CR60","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.cmet.2005.01.002","volume":"1","author":"MA Kennedy","year":"2005","unstructured":"Kennedy MA, Barrera GC, Nakamura K, Bald\u00e1n \u00c1, Tarr P, Fishbein MC, et al. ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation. Cell Metab. 2005;1(2):121\u201331.","journal-title":"Cell Metab"},{"issue":"34","key":"934_CR61","doi-asserted-by":"publisher","first-page":"20982","DOI":"10.1074\/jbc.272.34.20982","volume":"272","author":"Y Ji","year":"1997","unstructured":"Ji Y, Jian B, Wang N, Sun Y, Moya ML, Phillips MC, et al. Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux. J Biol Chem. 1997;272(34):20982\u20135.","journal-title":"J Biol Chem"},{"issue":"3","key":"934_CR62","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.jhep.2003.11.006","volume":"40","author":"JY Chiang","year":"2004","unstructured":"Chiang JY. Regulation of bile acid synthesis: pathways, nuclear receptors, and mechanisms. J Hepatol. 2004;40(3):539\u201351.","journal-title":"J Hepatol"},{"issue":"3","key":"934_CR63","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1002\/hep.26427","volume":"58","author":"T Li","year":"2013","unstructured":"Li T, Francl JM, Boehme S, Chiang JY. Regulation of cholesterol and bile acid homeostasis by the cholesterol 7alpha-hydroxylase\/steroid response element-binding protein 2\/microRNA-33a axis in mice. Hepatology. 2013;58(3):1111\u201321.","journal-title":"Hepatology"},{"issue":"9","key":"934_CR64","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1002\/emmm.201201228","volume":"4","author":"RM Allen","year":"2012","unstructured":"Allen RM, Marquart TJ, Albert CJ, et al. miR-33 controls the expression of biliary transporters, and mediates statin- and diet-induced hepatotoxicity. EMBO Mol Med. 2012;4(9):882\u201395.","journal-title":"EMBO Mol Med"},{"issue":"22","key":"934_CR65","doi-asserted-by":"publisher","first-page":"9232","DOI":"10.1073\/pnas.1102281108","volume":"108","author":"A Davalos","year":"2011","unstructured":"Davalos A, Goedeke L, Smibert P, et al. miR-33a\/b contribute to the regulation of fatty acid metabolism and insulin signaling. Proc Natl Acad Sci U S A. 2011;108(22):9232\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5985","key":"934_CR66","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1126\/science.1189123","volume":"328","author":"SH Najafi-Shoushtari","year":"2010","unstructured":"Najafi-Shoushtari SH, Kristo F, Li Y, Shioda T, Cohen DE, Gerszten RE, et al. MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis. Science. 2010;328(5985):1566\u20139.","journal-title":"Science"},{"issue":"1","key":"934_CR67","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/s42255-018-0004-9","volume":"1","author":"EJ Hennessy","year":"2019","unstructured":"\u2022\u2022 Hennessy EJ, van Solingen C, Scacalossi KR, et al. The long noncoding RNA CHROME regulates cholesterol homeostasis in primate. Nat Metab. 2019;1(1):98\u2013110 The findings from the study uncovers the long non-coding RNA CHROME as a central regulator of a set of microRNAs involved in cholesterol metabolism in hepatocytes and macrophages.","journal-title":"Nat Metab"},{"issue":"27","key":"934_CR68","doi-asserted-by":"publisher","first-page":"12228","DOI":"10.1073\/pnas.1005191107","volume":"107","author":"TJ Marquart","year":"2010","unstructured":"Marquart TJ, Allen RM, Ory DS, Baldan A. miR-33 links SREBP-2 induction to repression of sterol transporters. Proc Natl Acad Sci U S A. 2010;107(27):12228\u201332.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"40","key":"934_CR69","doi-asserted-by":"publisher","first-page":"17321","DOI":"10.1073\/pnas.1008499107","volume":"107","author":"T Horie","year":"2010","unstructured":"Horie T, Ono K, Horiguchi M, Nishi H, Nakamura T, Nagao K, et al. MicroRNA-33 encoded by an intron of sterol regulatory element-binding protein 2 (Srebp2) regulates HDL in vivo. Proc Natl Acad Sci U S A. 2010;107(40):17321\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"934_CR70","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1161\/ATVBAHA.113.301732","volume":"33","author":"N Rotllan","year":"2013","unstructured":"Rotllan N, Ramirez CM, Aryal B, Esau CC, Fernandez-Hernando C. Therapeutic silencing of microRNA-33 inhibits the progression of atherosclerosis in Ldlr-\/- mice\u2014brief report. Arterioscler Thromb Vasc Biol. 2013;33(8):1973\u20137.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"7","key":"934_CR71","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1172\/JCI57275","volume":"121","author":"KJ Rayner","year":"2011","unstructured":"Rayner KJ, Sheedy FJ, Esau CC, Hussain FN, Temel RE, Parathath S, et al. Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis. J Clin Invest. 2011;121(7):2921\u201331.","journal-title":"J Clin Invest"},{"key":"934_CR72","doi-asserted-by":"crossref","unstructured":"Rottiers V, Obad S, Petri A, et al: Pharmacological inhibition of a microRNA family in nonhuman primates by a seed-targeting 8-mer antimiR. Sci Transl Med 2013, 5(212):212ra162.","DOI":"10.1126\/scitranslmed.3006840"},{"key":"934_CR73","doi-asserted-by":"publisher","first-page":"2883","DOI":"10.1038\/ncomms3883","volume":"4","author":"T Horie","year":"2013","unstructured":"Horie T, Nishino T, Baba O, Kuwabara Y, Nakao T, Nishiga M, et al. MicroRNA-33 regulates sterol regulatory element-binding protein 1 expression in mice. Nat Commun. 2013;4:2883.","journal-title":"Nat Commun"},{"issue":"10","key":"934_CR74","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1161\/ATVBAHA.118.311409","volume":"38","author":"T Nishino","year":"2018","unstructured":"Nishino T, Horie T, Baba O, Sowa N, Hanada R, Kuwabara Y, et al. SREBF1\/microRNA-33b axis exhibits potent effect on unstable atherosclerotic plaque formation in vivo. Arterioscler Thromb Vasc Biol. 2018;38(10):2460\u201373.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"934_CR75","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1161\/CIRCRESAHA.118.314415","volume":"124","author":"NL Price","year":"2019","unstructured":"\u2022 Price NL, Rotllan N, Zhang X, et al. Specific disruption of Abca1 targeting largely mimics the effects of miR-33 knockout on macrophage cholesterol efflux and atherosclerotic plaque development. Circ Res. 2019;124(6):874\u201380 This study uses innovative techniques to show the specific effect of Abca1 targeting by miR-33 in cholesterol metabolism and atherosclerosis.","journal-title":"Circ Res"},{"issue":"6","key":"934_CR76","doi-asserted-by":"publisher","first-page":"e003376","DOI":"10.1161\/JAHA.112.003376","volume":"1","author":"T Horie","year":"2012","unstructured":"Horie T, Baba O, Kuwabara Y, Chujo Y, Watanabe S, Kinoshita M, et al. MicroRNA-33 deficiency reduces the progression of atherosclerotic plaque in ApoE-\/- mice. J Am Heart Assoc. 2012;1(6):e003376.","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"934_CR77","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.celrep.2017.10.023","volume":"21","author":"NL Price","year":"2017","unstructured":"Price NL, Rotllan N, Canfran-Duque A, et al. Genetic dissection of the impact of miR-33a and miR-33b during the progression of atherosclerosis. Cell Rep. 2017;21(5):1317\u201330.","journal-title":"Cell Rep"},{"issue":"5","key":"934_CR78","doi-asserted-by":"publisher","first-page":"e2006478118","DOI":"10.1073\/pnas.2006478118","volume":"118","author":"NL Price","year":"2021","unstructured":"\u2022 Price NL, Zhang X, Fernandez-Tussy P, et al. Loss of hepatic miR-33 improves metabolic homeostasis and liver function without altering body weight or atherosclerosis. Proc Natl Acad Sci U S A. 2021;118(5):e2006478118 The findings from this work suggest hepatic miR-33 in mice does not influence atherosclerosis and obesity but may be important for metabolic function.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"934_CR79","doi-asserted-by":"publisher","first-page":"5312","DOI":"10.1038\/srep05312","volume":"4","author":"T Horie","year":"2014","unstructured":"Horie T, Nishino T, Baba O, et al. MicroRNA-33b knock-in mice for an intron of sterol regulatory element-binding factor 1 (Srebf1) exhibit reduced HDL-C in vivo. Sci Rep. 2014;4:5312.","journal-title":"Sci Rep"},{"issue":"10","key":"934_CR80","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1161\/ATVBAHA.118.311617","volume":"38","author":"MM Hussain","year":"2018","unstructured":"Hussain MM, Goldberg IJ. Human microRNA-33b promotes atherosclerosis in Apoe(-\/-) mice. Arterioscler Thromb Vasc Biol. 2018;38(10):2272\u20135.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"13","key":"934_CR81","doi-asserted-by":"publisher","first-page":"e012609","DOI":"10.1161\/JAHA.119.012609","volume":"8","author":"S Koyama","year":"2019","unstructured":"Koyama S, Horie T, Nishino T, Baba O, Sowa N, Miyasaka Y, et al. Identification of differential roles of microRNA-33a and -33b during atherosclerosis progression with genetically modified mice. J Am Heart Assoc. 2019;8(13):e012609.","journal-title":"J Am Heart Assoc"},{"issue":"23","key":"934_CR82","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1056\/NEJMoa1414266","volume":"372","author":"RA Hayward","year":"2015","unstructured":"Hayward RA, Reaven PD, Wiitala WL, Bahn GD, Reda DJ, Ge L, et al. Follow-up of glycemic control and cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2015;372(23):2197\u2013206.","journal-title":"N Engl J Med"},{"issue":"7","key":"934_CR83","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s11886-015-0607-7","volume":"17","author":"MO Gore","year":"2015","unstructured":"Gore MO, McGuire DK, Lingvay I, Rosenstock J. Predicting cardiovascular risk in type 2 diabetes: the heterogeneity challenges. Curr Cardiol Rep. 2015;17(7):607.","journal-title":"Curr Cardiol Rep"},{"issue":"3","key":"934_CR84","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1161\/CIRCRESAHA.117.305624","volume":"117","author":"D Karunakaran","year":"2015","unstructured":"Karunakaran D, Thrush AB, Nguyen MA, Richards L, Geoffrion M, Singaravelu R, et al. Macrophage mitochondrial energy status regulates cholesterol efflux and is enhanced by anti-miR33 in atherosclerosis. Circ Res. 2015;117(3):266\u201378.","journal-title":"Circ Res"},{"issue":"5","key":"934_CR85","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1161\/ATVBAHA.116.307282","volume":"36","author":"M Ouimet","year":"2016","unstructured":"Ouimet M. Hennessy EJ, van Solingen C, et al: miRNA targeting of oxysterol-binding protein-like 6 regulates cholesterol trafficking and efflux. Arterioscler Thromb Vasc Biol. 2016;36(5):942\u201351.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"934_CR86","doi-asserted-by":"publisher","first-page":"4334","DOI":"10.1172\/JCI81676","volume":"125","author":"M Ouimet","year":"2015","unstructured":"Ouimet M, Ediriweera HN, Gundra UM, Sheedy FJ, Ramkhelawon B, Hutchison SB, et al. MicroRNA-33-dependent regulation of macrophage metabolism directs immune cell polarization in atherosclerosis. J Clin Invest. 2015;125(12):4334\u201348.","journal-title":"J Clin Invest"},{"issue":"5","key":"934_CR87","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1161\/CIRCRESAHA.116.309528","volume":"120","author":"M Nishiga","year":"2017","unstructured":"Nishiga M, Horie T, Kuwabara Y, Nagao K, Baba O, Nakao T, et al. MicroRNA-33 controls adaptive fibrotic response in the remodeling heart by preserving lipid raft cholesterol. Circ Res. 2017;120(5):835\u201347.","journal-title":"Circ Res"},{"issue":"5","key":"934_CR88","first-page":"488","volume":"113","author":"K Huang","year":"2017","unstructured":"Huang K, Bao H, Yan ZQ, Wang L, Zhang P, Yao QP, et al. MicroRNA-33 protects against neointimal hyperplasia induced by arterial mechanical stretch in the grafted vein. Cardiovasc Res. 2017;113(5):488\u201397.","journal-title":"Cardiovasc Res"},{"issue":"11","key":"934_CR89","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.1161\/ATVBAHA.111.232066","volume":"31","author":"CM Ramirez","year":"2011","unstructured":"Ramirez CM, Davalos A, Goedeke L, et al. MicroRNA-758 regulates cholesterol efflux through posttranscriptional repression of ATP-binding cassette transporter A1. Arterioscler Thromb Vasc Biol. 2011;31(11):2707\u201314.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"10","key":"934_CR90","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1016\/j.febslet.2012.03.068","volume":"586","author":"D Sun","year":"2012","unstructured":"Sun D, Zhang J, Xie J, Wei W, Chen M, Zhao X. MiR-26 controls LXR-dependent cholesterol efflux by targeting ABCA1 and ARL7. FEBS Lett. 2012;586(10):1472\u20139.","journal-title":"FEBS Lett"},{"issue":"1","key":"934_CR91","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.atherosclerosis.2014.02.008","volume":"234","author":"M Zhang","year":"2014","unstructured":"Zhang M, Wu JF, Chen WJ, Tang SL, Mo ZC, Tang YY, et al. MicroRNA-27a\/b regulates cellular cholesterol efflux, influx and esterification\/hydrolysis in THP-1 macrophages. Atherosclerosis. 2014;234(1):54\u201364.","journal-title":"Atherosclerosis"},{"issue":"2","key":"934_CR92","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1161\/ATVBAHA.114.304878","volume":"35","author":"S Meiler","year":"2015","unstructured":"Meiler S, Baumer Y, Toulmin E, Seng K, Boisvert WA. MicroRNA 302a is a novel modulator of cholesterol homeostasis and atherosclerosis. Arterioscler Thromb Vasc Biol. 2015;35(2):323\u201331.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"934_CR93","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.atherosclerosis.2014.07.005","volume":"236","author":"YC Lv","year":"2014","unstructured":"Lv YC, Tang YY, Peng J, Zhao GJ, Yang J, Yao F, et al. MicroRNA-19b promotes macrophage cholesterol accumulation and aortic atherosclerosis by targeting ATP-binding cassette transporter A1. Atherosclerosis. 2014;236(1):215\u201326.","journal-title":"Atherosclerosis"},{"issue":"8","key":"934_CR94","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1161\/CIRCRESAHA.112.277277","volume":"111","author":"SL Hazen","year":"2012","unstructured":"Hazen SL, Smith JD. An antiatherosclerotic signaling cascade involving intestinal microbiota, microRNA-10b, and ABCA1\/ABCG1-mediated reverse cholesterol transport. Circ Res. 2012;111(8):948\u201350.","journal-title":"Circ Res"},{"issue":"4","key":"934_CR95","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1160\/TH13-11-0905","volume":"112","author":"F Sala","year":"2014","unstructured":"Sala F, Aranda JF, Rotllan N, Ram\u00edrez C, Aryal B, Elia L, et al. MiR-143\/145 deficiency attenuates the progression of atherosclerosis in Ldlr-\/-mice. Thromb Haemost. 2014;112(4):796\u2013802.","journal-title":"Thromb Haemost"},{"issue":"12","key":"934_CR96","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1161\/CIRCRESAHA.112.300648","volume":"112","author":"TQ de Aguiar Vallim","year":"2013","unstructured":"de Aguiar Vallim TQ, Tarling EJ, Kim T, Civelek M, Bald\u00e1n \u00c1, Esau C, et al. MicroRNA-144 regulates hepatic ATP binding cassette transporter A1 and plasma high-density lipoprotein after activation of the nuclear receptor farnesoid X receptor. Circ Res. 2013;112(12):1602\u201312.","journal-title":"Circ Res"},{"issue":"2","key":"934_CR97","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1161\/ATVBAHA.119.313633","volume":"40","author":"J Cheng","year":"2020","unstructured":"Cheng J, Cheng A, Clifford BL, Wu X, Hedin U, Maegdefessel L, et al. MicroRNA-144 silencing protects against atherosclerosis in male, but not female mice. Arterioscler Thromb Vasc Biol. 2020;40(2):412\u201325.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"934_CR98","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nm820","volume":"9","author":"SB Joseph","year":"2003","unstructured":"Joseph SB, Castrillo A, Laffitte BA, Mangelsdorf DJ, Tontonoz P. Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nat Med. 2003;9(2):213\u20139.","journal-title":"Nat Med"},{"issue":"7","key":"934_CR99","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1172\/JCI45444","volume":"121","author":"X Liao","year":"2011","unstructured":"Liao X, Sharma N, Kapadia F, Zhou G, Lu Y, Hong H, et al. Kruppel-like factor 4 regulates macrophage polarization. J Clin Invest. 2011;121(7):2736\u201349.","journal-title":"J Clin Invest"},{"issue":"24","key":"934_CR100","doi-asserted-by":"publisher","first-page":"5035","DOI":"10.1128\/MCB.01002-12","volume":"32","author":"Z Hu","year":"2012","unstructured":"Hu Z, Shen WJ, Kraemer FB, Azhar S. MicroRNAs 125a and 455 repress lipoprotein-supported steroidogenesis by targeting scavenger receptor class B type I in steroidogenic cells. Mol Cell Biol. 2012;32(24):5035\u201345.","journal-title":"Mol Cell Biol"},{"issue":"10","key":"934_CR101","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1128\/MCB.01580-12","volume":"33","author":"L Wang","year":"2013","unstructured":"Wang L, Jia XJ, Jiang HJ, du Y, Yang F, Si SY, et al. MicroRNAs 185, 96, and 223 repress selective high-density lipoprotein cholesterol uptake through posttranscriptional inhibition. Mol Cell Biol. 2013;33(10):1956\u201364.","journal-title":"Mol Cell Biol"},{"issue":"9","key":"934_CR102","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.18632\/aging.101541","volume":"10","author":"F Zhang","year":"2018","unstructured":"Zhang F, Zhang R, Zhang X, Wu Y, Li X, Zhang S, et al. Comprehensive analysis of circRNA expression pattern and circRNA-miRNA-mRNA network in the pathogenesis of atherosclerosis in rabbits. Aging (Albany NY). 2018;10(9):2266\u201383.","journal-title":"Aging (Albany NY)"},{"issue":"2","key":"934_CR103","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1177\/1535370218822988","volume":"244","author":"X Gong","year":"2019","unstructured":"Gong X, Wu G, Zeng C. Role of circular RNAs in cardiovascular diseases. Exp Biol Med (Maywood). 2019;244(2):73\u201382.","journal-title":"Exp Biol Med (Maywood)"},{"issue":"1","key":"934_CR104","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41392-020-0105-2","volume":"5","author":"C Zhang","year":"2020","unstructured":"Zhang C, Chen K, Wei R, Fan G, Cai X, Xu L, et al. The circFASN\/miR-33a pathway participates in tacrolimus-induced dysregulation of hepatic triglyceride homeostasis. Signal Transduct Target Ther. 2020;5(1):23.","journal-title":"Signal Transduct Target Ther"},{"issue":"12","key":"934_CR105","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1089\/dna.2019.4865","volume":"38","author":"L Wang","year":"2019","unstructured":"Wang L, Zheng Z. Feng X, et al: circRNA\/lncRNA-miRNA-mRNA network in oxidized, low-density, lipoprotein-induced foam cells. DNA Cell Biol. 2019;38(12):1499\u2013511.","journal-title":"DNA Cell Biol"},{"issue":"2","key":"934_CR106","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/s41419-020-2293-7","volume":"11","author":"X Jin","year":"2020","unstructured":"Jin X, Gao J, Zheng R, Yu M, Ren Y, Yan T, et al. Antagonizing circRNA_002581-miR-122-CPEB1 axis alleviates NASH through restoring PTEN-AMPK-mTOR pathway regulated autophagy. Cell Death Dis. 2020;11(2):123.","journal-title":"Cell Death Dis"},{"key":"934_CR107","doi-asserted-by":"crossref","unstructured":"Chen C, Zhang X, Deng Y, Cui Q, Zhu J, Ren H, Liu Y, Hu X, Zuo J, Peng Y Regulatory roles of circRNAs in adipogenesis and lipid metabolism: emerging insights into lipid-related diseases. FEBS J 2020.","DOI":"10.1111\/febs.15525"}],"container-title":["Current Atherosclerosis Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-021-00934-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11883-021-00934-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-021-00934-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T19:30:09Z","timestamp":1675279809000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11883-021-00934-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,10]]},"references-count":107,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["934"],"URL":"https:\/\/doi.org\/10.1007\/s11883-021-00934-3","relation":{},"ISSN":["1523-3804","1534-6242"],"issn-type":[{"value":"1523-3804","type":"print"},{"value":"1534-6242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,10]]},"assertion":[{"value":"20 April 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"CF-H has a patent on the use of miR-33 inhibitors to treat inflammation. The other authors report no conflicts.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"33"}}